![Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years | Scientific Reports Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-55213-8/MediaObjects/41598_2019_55213_Fig1_HTML.png)
Comparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years | Scientific Reports
Jenny A. Petersen - Director, Clinical Trial Disclosure and Transparency - Alnylam Pharmaceuticals | LinkedIn
![Frontiers | Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions Frontiers | Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions](https://www.frontiersin.org/files/Articles/1052386/falgy-04-1052386-HTML-r1/image_m/falgy-04-1052386-g001.jpg)
Frontiers | Multidisciplinary approaches to identifying and managing global airways disease: Expert recommendations based on qualitative discussions
![Niemann-Pick type C disease: Journey to diagnosis Slide set for [INSERT SPECIALITY] [INSERT DATE] This survey was sponsored by Actelion Pharmaceuticals. - ppt download Niemann-Pick type C disease: Journey to diagnosis Slide set for [INSERT SPECIALITY] [INSERT DATE] This survey was sponsored by Actelion Pharmaceuticals. - ppt download](https://slideplayer.com/7601673/25/images/slide_1.jpg)
Niemann-Pick type C disease: Journey to diagnosis Slide set for [INSERT SPECIALITY] [INSERT DATE] This survey was sponsored by Actelion Pharmaceuticals. - ppt download
![January's top stories: J&J to acquire Actelion for $30bn, Takeda to acquire ARIAD for $5.2bn - Pharmaceutical Technology January's top stories: J&J to acquire Actelion for $30bn, Takeda to acquire ARIAD for $5.2bn - Pharmaceutical Technology](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2017/09/main-1359-267x200.jpg)
January's top stories: J&J to acquire Actelion for $30bn, Takeda to acquire ARIAD for $5.2bn - Pharmaceutical Technology
Biomarker counselling, disclosure of diagnosis and follow‐up in patients with mild cognitive impairment: A European Alzheimer
![Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia - Kleineidam - Alzheimer's & Dementia - Wiley Online Library Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia - Kleineidam - Alzheimer's & Dementia - Wiley Online Library](https://alz-journals.onlinelibrary.wiley.com/cms/asset/a97b6d18-8c18-4b29-b411-887a96e5e632/alz12785-fig-0002-m.jpg)
Disentangling the relationship of subjective cognitive decline and depressive symptoms in the development of cognitive decline and dementia - Kleineidam - Alzheimer's & Dementia - Wiley Online Library
![Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). - Abstract - Europe PMC Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). - Abstract - Europe PMC](https://europepmc.org/articles/PMC4689180/bin/cir-132-2403-g008.jpg)
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). - Abstract - Europe PMC
![JPM | Free Full-Text | Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community JPM | Free Full-Text | Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community](https://www.mdpi.com/jpm/jpm-12-01997/article_deploy/html/images/jpm-12-01997-g001.png)
JPM | Free Full-Text | Greek Guidelines for the Management of COPD, a Proposal of a Holistic Approach Based on the needs of the Greek Community
![PDF) The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome PDF) The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome](https://i1.rgstatic.net/publication/259701419_The_selective_orexin_receptor_1_antagonist_ACT-335827_in_a_rat_model_of_diet-induced_obesity_associated_with_metabolic_syndrome/links/0c960535e47c7a2935000000/largepreview.png)
PDF) The selective orexin receptor 1 antagonist ACT-335827 in a rat model of diet-induced obesity associated with metabolic syndrome
![PDF) SAT0652-HPR (2020) CHRONIC DISEASE MANAGEMENT AND HEALTH TECHNOLOGY READINESS OF PATIENTS WITH SYSTEMIC SCLEROSIS IN SWITZERLAND – A CROSS-SECTIONAL STUDY PDF) SAT0652-HPR (2020) CHRONIC DISEASE MANAGEMENT AND HEALTH TECHNOLOGY READINESS OF PATIENTS WITH SYSTEMIC SCLEROSIS IN SWITZERLAND – A CROSS-SECTIONAL STUDY](https://i1.rgstatic.net/publication/342311736_SAT0652-HPR_2020_CHRONIC_DISEASE_MANAGEMENT_AND_HEALTH_TECHNOLOGY_READINESS_OF_PATIENTS_WITH_SYSTEMIC_SCLEROSIS_IN_SWITZERLAND_-_A_CROSS-SECTIONAL_STUDY/links/60181d6092851c2d4d0bb744/largepreview.png)
PDF) SAT0652-HPR (2020) CHRONIC DISEASE MANAGEMENT AND HEALTH TECHNOLOGY READINESS OF PATIENTS WITH SYSTEMIC SCLEROSIS IN SWITZERLAND – A CROSS-SECTIONAL STUDY
![PDF) The analysis of five custom generative design software and it's implications on the design process PDF) The analysis of five custom generative design software and it's implications on the design process](https://www.researchgate.net/profile/Gil-Barros/publication/235920689/figure/fig2/AS:927000923500546@1598025651735/Actelion-Imagery-Wizard-screenshot-http_Q320.jpg)
PDF) The analysis of five custom generative design software and it's implications on the design process
![Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data - Didden - 2023 - Pulmonary Circulation - Wiley Online Library Time to diagnosis of pulmonary hypertension and diagnostic burden: A retrospective analysis of nationwide US healthcare data - Didden - 2023 - Pulmonary Circulation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/586f192a-a449-4047-b85b-b060e0b55db8/pul2.v13.1.cover.jpg?trick=1675856950978)